HEMOSTASIS COAGULATION ROUTINE REAGENTS ANTICOAGULANT MONITORING DOAC RIVAROXABAN
TECHNOVIEW® Rivaroxaban Cont Low
Low control plasmas for the rivaroxaban assay.
TECHNOVIEW® Rivaroxaban Control Low quality control plasmas are titrated to approximately 50 ng / mL, optimized for anti-FXa methods.
Informations
Rivaroxaban is a highly selective direct inhibitor of FXa.
This inhibition interrupts the intrinsic pathway of the blood coagulation cascade, inhibiting the formation of thrombin and the development of thrombi. It does not inhibit thrombin and has no effect on platelets.
Documentation
Download the product sheetPrice list, safety data sheets and notices are accessible to our registered customers.
Lyophilized plasmas
References
| 4-5090172 | Vial | 5 x 1.0 mL |
